Comparative Study
doi: 10.1002/jmv.1890030303.
Attenuated influenza produced by experimental intranasal inoculation
- PMID: 479857
- DOI: 10.1002/jmv.1890030303
Item in Clipboard
Comparative Study
Attenuated influenza produced by experimental intranasal inoculation
J Med Virol.
1979.
Abstract
To assess the relative effect of natural versus experimental influenza illness on pulmonary function, we compared 43 normal adults with documented nonpneumonic influenza A infection during three outbreaks, 1974 (A/Port Chalmers/74), 1975 (A/Port Chalmers/74), and 1976 (A/Victoria/75) to 24 normal volunteers following nasal inoculation with wild-type influenza A/England/42/72, A/Scotland/74 or A/Victoria/75. In naturally acquired illness, abnormalities in small airway functiion and transiently increase airway reactivity were observed. In contrast, no such dysfunction was observed in experimentally induced illness. This group manifested milder illness and significantly shorter duration of cough.
Similar articles
-
Bronchial reactivity in experimental infections with influenza virus.J Infect Dis. 1982 Oct;146(4):468-71. doi: 10.1093/infdis/146.4.468. J Infect Dis. 1982. PMID: 6750006
-
Lower airway responses to influenza A virus in healthy allergic and nonallergic subjects.Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):661-4. doi: 10.1164/ajrccm.154.3.8810602. Am J Respir Crit Care Med. 1996. PMID: 8810602
-
Efficacy of live attenuated influenza A/Scotland/74 (H3N2) virus vaccine against challenge with influenza A/Victoria/3/75 (H3N2) virus.J Infect Dis. 1977 Dec;136(6):746-53. doi: 10.1093/infdis/136.6.746. J Infect Dis. 1977. PMID: 925382 Clinical Trial.
-
Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.Biol Chem. 2004 Nov;385(11):1029-34. doi: 10.1515/BC.2004.133. Biol Chem. 2004. PMID: 15576322 Review.
-
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
Cited by
-
What were the historical reasons for the resistance to recognizing airborne transmission during the COVID-19 pandemic?Indoor Air. 2022 Aug;32(8):e13070. doi: 10.1111/ina.13070. Indoor Air. 2022. PMID: 36040283 Free PMC article. Review.
-
The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections.Clin Infect Dis. 2016 Feb 15;62(4):431-437. doi: 10.1093/cid/civ909. Epub 2015 Oct 30. Clin Infect Dis. 2016. PMID: 26518469 Free PMC article.
-
Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.J Clin Microbiol. 1986 Sep;24(3):336-42. doi: 10.1128/jcm.24.3.336-342.1986. J Clin Microbiol. 1986. PMID: 3531226 Free PMC article. Clinical Trial.
-
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.Vaccine. 2019 Aug 14;37(35):4823-4829. doi: 10.1016/j.vaccine.2019.06.080. Vaccine. 2019. PMID: 31362819 Free PMC article.
-
Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale.PLoS One. 2021 Oct 21;16(10):e0258482. doi: 10.1371/journal.pone.0258482. eCollection 2021. PLoS One. 2021. PMID: 34673782 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
